Developing new medicine is really a high-priced and unsure method, and plenty of possible drugs under no circumstances enable it to be to industry. Only about 12 percent of drugs moving into medical trials are in the end authorized for introduction by the FDA. In the latest scientific tests, estimates of the common R&D Price for every new drug ran